IDIVAL has just published the progress of its annual report summarizing the main milestones and data of activity developed, both in terms of scientific production and economic results.
Throughout its 22 pages prologued by the President of the IDIVAL Board of Trustees and Counselor of Health of the Government of Cantabria, Maria Luisa Real, the memory recalls the organizational structure of IDIVAL that has 30 research groups structured in 6 areas (Cancer, Neurosciences , Metabolism, Infection and Immunity, Transplantation and Transverse Areas), and a powerful support structure for research that depend on a Board of Trustees formed by the Government of Cantabria and the University of Cantabria.
The progress of the memory also gathers the main milestones of the year and names 20 papers in which researchers from the Institute of special relevance have participated.
Finally, it reflects the main data of scientific activity, which includes 493 papers, an impact factor of 1915, and economic figures with a total income of almost € 7 million, which comes from competitive financing of 35%, private agreements of 33% and financing from the Government of Cantabria by 31%. On the whole the data indicate a good activity that is maintained with respect to 2015.
Link to the progress of the IDIVAL
IDIVAL has just published the progress of its annual report summarizing the main milestones and data of activity developed, both in terms of scientific production and economic results. Throughout its 22 pages prologued by the President of the IDIVAL Board of Trustees and Counselor of Health of the Government of Cantabria, Maria Luisa Real, the […]
Expediente de contratación IDIVAL 02/2017
Pliego de Cláusulas Administrativas Particulares
Pliego de Prescripciones Técnicas Particulares
Expediente de contratación IDIVAL 02/2017 Pliego de Cláusulas Administrativas Particulares Pliego de Prescripciones Técnicas Particulares Resolución de adjudicación
The next conference of Santander Biomedical Lectures Program organized by IDIVAL, the University of Cantabria and the IBBTEC will take place on the 30th of March. The conference will be given by John F. Cryan, Associate Professor from the Department of Anatomy & Neuroscience at University College Cork, Irlanda.
The session will focus on: “The Microbiome- A Key Regulator of Brain & Behaviour Across the Lifespan”.
John F. Cryan is Professor & Chair, Dept. of Anatomy & Neuroscience, University College Cork and serves on the University’s Governing Body. He is also a principal investigator in the APC Microbiome Institute. He received a B.Sc. (Hons) and PhD from the National University of Ireland, Galway, Ireland. He was a visiting fellow at the Dept Psychiatry, University of Melbourne, Australia, which was followed by postdoctoral fellowships at the University of Pennsylvania, Philadelphia, USA and The Scripps Research Institute, La Jolla, California.
He spent four years at the Novartis Institutes for BioMedical Research in Basel, Switzerland, as a LabHead, Behavioural Pharmacology prior to joining UCC in 2005. Prof. Cryan's current research is focused on understanding the interaction between brain, gut & microbiome and how it applies to stress, psychiatric and immune-related disorders at key time-windows across the lifespan. Prof. Cryan has published over 360 peer-reviewed articles and book chapters and has an H-index of 76. He is a Senior Editor of Neuropharmacology and of Nutritional Neuroscience and an Editor of British Journal of Pharmacology. He is on the editorial board of a further 15 journals. He has edited three books including “Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease” (Springer Press, 2014). He has received numerous awards including UCC Researcher of the Year in 2012; the University of Utrecht Award for Excellence in Pharmaceutical Research in 2013 and being named on the Thomson Reuters Highly Cited Researcher list in 2014. He was a TEDMED speaker in Washington in 2014 and is President-elect of the European Behavioural Pharmacology Society.
Summary of the Lecture: The brain-gut-microbiota axis is emerging as a research area of increasing interest for those investigating the biological and physiological basis of neurodevelopmental, age-related and neurodegenerative disorders. The routes of communication between the gut and brain include the vagus nerve, the immune system, tryptophan metabolism, via the enteric nervous system or by way of microbial metabolites such as short chain fatty acids. Studies in animal models have shown that the development of an appropriate stress response is dependent on the microbiota. Developmentally, a variety of factors can impact the microbiota in early life including mode of birth delivery, antibiotic exposure, mode of nutritional provision, infection, stress as well as host genetics. At the other extreme of life, individuals who age with considerable ill health tend to show narrowing in microbial diversity. Stress can significantly impact the microbiota-gut-brain axis at all stages across the lifespan. Recently, the gut microbiota has been implicated in a variety of conditions including autism, schizophrenia and Parkinson’s disease. Moreover, fundamental brain processes from adult hippocampal neurogenesis to myelination to microglia activation have been shown to be regulated by the microbiome. Further studies will focus on understanding the mechanisms underlying such brain effects and developing nutritional and microbial-based intervention strategies.
The conference will be open to the general public and it will take place at Marques de Valdecilla University Hospital, Salon Tellez (Pavilion 16) at 8.15am.
Professor Cryan will be in Santander throughout the day, to exchange experiences with members of the scientific and clinical community. Furthermore, He will visit the Research centers of our community to talk with all the interested scientists.
Those professionals who would like to meet with professor Cryan during his stay can contact with the department at gesval1@idival.org
The next conference of Santander Biomedical Lectures Program organized by IDIVAL, the University of Cantabria and the IBBTEC will take place on the 30th of March. The conference will be given by John F. Cryan, Associate Professor from the Department of Anatomy & Neuroscience at University College Cork, Irlanda. The session will focus on: “The […]
Worldwide Cancer Research open a new call to support research that might in future help reduce the incidence of cancer or improve cancer survival. We award grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer.
Call for submissions proposals will be open from 29th March to 21st April.
The principal investigator must be a suitably qualified researcher (minimum of PhD followed by three years research experience, or equivalent qualification or research experience).
– Have at least three years of postdoctoral research activity or equivalent research experience.
– The PI must be employed at a recognised, non-profit research institution anywhere in the world. The PI must have a contract of employment that will last for at least the duration of the grant requested, or be able to show evidence that their current contract would be extended if the grant were awarded.
– A research group can only submit a single application to Worldwide Cancer Research in a 12-month period.T
Characteristics of the grant:
– The maximum budget permitted is £250,000.
– Worldwide Cancer Research offers grants for 1-3 year research projects.
– External reviewers are asked to assess applications on the following criteria:
Once registered on the online system you will be able to begin preparing an application when a grant round opens. The April 2017 grant round will open on Wednesday 22nd March. Completed applications can only be submitted during the submission period, Wednesday 29th March until Friday 21st April.
More information: https://www.worldwidecancerresearch.org/funding-for-research/make-an-application/
Worldwide Cancer Research open a new call to support research that might in future help reduce the incidence of cancer or improve cancer survival. We award grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer. Call for submissions proposals will be open from 29th March to 21st […]
El Diario Montañés
Inn-Val Call, for the development of innovation projects in Valdecilla University Hospital, is opened until de the 30th of April. IDIVAL focus on promoting the development of healthcare innovation projects and the transfer of knowledge to the society and market, in addition to integrating agents of the health environment, companies and the University of Cantabria.
This call is open to the field of Biomedicine, Electromedicine, Pharmaceutical Technologies, Technologies and Health Sciences, as well as Biotechnology, Chemical Technology and Materials applied to human health and Information and Communication Technologies applied to health.
This call has a budget of € 100,000, and the maximum amount per project is € 25,000. The duration of the projects will be 1 to 2 years. The aid granted may finance part or the whole project.
Projects presented must have a principal researcher who will have a working relationship with IDIVAL, the Cantabrian Health Service, or the University of Cantabria as a teacher linked to the care activity or personnel of an IDIVAL research group.
All the projects submitted must choose one of the following options:
Option A. Development of innovative health technologies. Includes development of health products, services, diagnostic tools, medical and / or management software or new therapies, including drugs. Projects related to ergonomics, usability and human factor are considered of special interest.
Option B. Assistance innovation. Clinical and / or technological validation of a health technology and development, implantation and its validation in a clinical environment of new processes or assistance techniques. Health technology is understood as the set of medical and surgical devices and procedures used in health care, including its organizational and support systems, especially those related with the treatment of chronic patients.
Deadline for submission projects is the 30th of April.
More information: IDIVAL grants
Inn-Val Call, for the development of innovation projects in Valdecilla University Hospital, is opened until de the 30th of April. IDIVAL focus on promoting the development of healthcare innovation projects and the transfer of knowledge to the society and market, in addition to integrating agents of the health environment, companies and the University of Cantabria. This call […]
El Diario Montañés Europa Press Noticiaspress 20 Minutos La Vanguardia UNICAN
Europa press El Diario Montañés El Diario.es Cadena Ser
El Diario Montañés
The eighth session of the Program of lectures Valdecilla Progress Reports will take place on the 22nd of March. The conference will be given by Fernanda Genre, Post-doctoral contract Sara Borrell, grant from the Institute of Health Carlos III, at the IDIVAL’s Genetic epidemiology and atherosclerosis in systemic inflammatory diseases group leaded by Dr. Miguel Ángel González-Gay Mantecón.
The session will be about “Cardiovascular risk in spondyloarthropaties” and is briefly summarized below:
During the last years, the Epidemiology, genetics and atherosclerosis research group on systemic inflammatory diseases has focused the studies on the clinical epidemiology of different inflammatory pathologies such as rheumatoid arthritis, vasculitis and systemic lupus erythematosus, among others. In addition, taking into account the high incidence of cardiovascular disease in patients diagnosed with such diseases, the group has been searching for gene polymorphisms, serum biomarkers and non-invasive clinical markers that could help to stratify patients according to cardiovascular risk, serving as potential new tools for more personalized therapies. In this context, the group has recently started a line of research aimed to assess cardiovascular risk in spondyloarthropaties. For this purpose, this line of research will evaluate the influence of different serum biomarkers and genetic factors (both regarding gene polymorphisms and gene expression profiles) on the development of cardiovascular disease, combined with carotid ultrasound and imaging techniques (to assess the presence of surrogate markers of cardiovascular disease), in a large cohort of Spanish individuals diagnosed with different spondyloarthropaties. The main aim of this line of research is to identify markers that could be of use for the early diagnosis of spondyloarthritis patients with high cardiovascular risk that may need a complementary therapy, thus avoiding or delaying the development of cardiovascular disease.
This program of seminars is given by young researchers on the field of IDIVAL’s clinic and laboratories. Speakers will explain the scientific advances of their current research projects. With the idea of debating and networking, the main goal of these meetings, all the predoctoral contracts, Post-MIR Valdecilla López Albo researchers, Río Hortega and Inn-Val grants are invited to attend to these sessions as part of their training.
The meeting will take place on the 22nd of March in lecture room 4-5, pavilion 16 of the HUMV (1st floor) and has a capacity of 30 people. The session will be given in English and will last around 30 minutes and follow by a debate.
Researchers who attend 80% of the meetings throughout the academic year will receive a certificate of assistance.
For any questions regarding Progress Reports sessions, please contact the department at gesval1@idival.org
The eighth session of the Program of lectures Valdecilla Progress Reports will take place on the 22nd of March. The conference will be given by Fernanda Genre, Post-doctoral contract Sara Borrell, grant from the Institute of Health Carlos III, at the IDIVAL’s Genetic epidemiology and atherosclerosis in systemic inflammatory diseases group leaded by Dr. Miguel Ángel […]
